BMJ Best Practice

参考文献

关键文献

Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int. 2006;70:1403-1412.

参考文章

1.  Malafronte P, Mastroianni-Kirsztajn G, Betônico GN, et al. Paulista Registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant. 2006;21:3098-3105.

2.  Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:172-182.

3.  Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24:717-732.

4.  D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994;46:1223-1241.

5.  Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011;364:689-690.

6.  Wheeler DC. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. J Nephrol. 2001;14(suppl 4):S70-S75.

7.  Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002;62:1379-1384.

8.  Kim SW, Frokiaer J, Nielsen S. Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel. Nephrology (Carlton). 2007;12(suppl 3):S8-S10.

9.  van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011;26:881-892.

10.  Zhang S, Audard V, Fan Q, et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol. 2011;169:94-106.

11.  Gbadegesin R, Lavin P, Foreman J, et al. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol. 2011;26:1001-1015.

12.  Elie V, Fakhoury M, Deschênes G, et al. Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol. 2012;27:1249-1256.

13.  El Bakkali L, Rodrigues Pereira R, Kuik DJ, et al. Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241-1246.

14.  Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336:1185-1189.

15.  Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis. 2003;42:1107-1113.

16.  Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251-2260.

17.  Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27:322-328.

18.  Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997;30:621-631.

19.  Soo YO, Chow KM, Lam CW, et al. A whitened face woman with nephrotic syndrome. Am J Kidney Dis. 2003;41:250-253.

20.  Parry C, Eaton J. Kohl: a lead-hazardous eye makeup from the Third World to the First World. Environ Health Perspect. 1991;94:121-123.

21.  Aslam M, Davis SS, Healy MA. Heavy metals in some Asian medicines and cosmetics. Public Health. 1979;93:274-284.

22.  Sin KW, Tsang HF. Large scale mercury exposure due to a cream cosmetic: community-wide case series. Hong Kong Med J. 2003;9:329-334.

23.  Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson nodule. Hum Pathol. 1993;24:77-89.

24.  Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17:3458-3471.

25.  Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int. 2006;70:1403-1412.

26.  Bradwell AR, Carr-Smith HD, Mead GP, et al. Serum test for assessment of patients with Bence Jones myeloma. Lancet. 2003;361:489-491.

使用此内容应接受我们的免责声明